Brought to you by 
Cepheid gets European distribution rights to SpeeDx's molecular diagnostics
24 Apr 2019
Executive Summary
SpeeDx Pty. Ltd. licensed Danaher Corp.'s Cepheid subsidiary rights to distribute its PlexPCR and ResistancePlus molecular diagnostics in the UK, Germany, France, and Italy.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cepheid gets European distribution rights to SpeeDx's molecular diagnostics
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice